Krystal Biotech Retained Earnings (Accumulated Deficit) 2017-2024 | KRYS
Krystal Biotech retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-0.253B, a 29.49% decline year-over-year.
- Krystal Biotech retained earnings (accumulated deficit) for 2023 were $-0.27B, a 3.89% decline from 2022.
- Krystal Biotech retained earnings (accumulated deficit) for 2022 were $-0.281B, a 99.43% increase from 2021.
- Krystal Biotech retained earnings (accumulated deficit) for 2021 were $-0.141B, a 97.69% increase from 2020.